1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 21464406 | Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma. | 2011 May 20 | 1 |